Health Care M&A Deals, Week Ending November 16, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Catapult Learning, Inc. Capital Education Group N/A WindRose Health Investors, LLC Traditions Behavioral Health N/A Biotechnology Acquirer Target Price United Therapeutics Corp. Global license to ralinepag $800,000,000 eHealth Acquirer... Read More »
It’s a Glass Half-Something View of Healthcare M&A
If you only saw one story regarding Capital One Healthcare’s (NYSE: COF) recent industry survey, then you only saw one view of where the respondents think the industry is heading. Every year, Capital One surveys a group of healthcare services executives and private equity firms on their opinions regarding the industry’s business performance, likely merger and acquisition activity, emerging growth segments, etc. Last September, 123 CEOs, CFOs and other senior executives and PE investors responded, and the results were published as an infographic. “Healthcare Industry Optimism Reaches New Heights” was the title, followed by a graphic showing that 72% of respondents... Read More »
Health Care M&A Deals, Week Ending November 9, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price BayMark Health Services SpecialCare Hospital Management N/A FHE Health Group Treatment Partners of America N/A Biotechnology Acquirer Target Price Eli Lilly and Company License to immuno-oncology therapies $25,000,000... Read More »
Fourth Quarter 2018 Blasts Off with Heavy Deal Volume
Healthcare transactions kicked into high gear in October, with preliminary data showing a monthly total of 176 deals, the highest monthly tally reported this year. It bests September’s 144 deals by 22%, and the year-ago volume of 151 deals by 17%. Eight of the 13 sectors saw solid gains compared with October 2017 results. The Long-Term Care sector saw a boost to 30 deals, up 15% compared with the previous month, and 25% year over year. Behavioral Health Care, Physician Medical Groups and Other Services were strong performers among the services sectors, and the usually quiet Laboratories, MRI & Dialysis sector showed a surge (relatively speaking) of 80% compared with the previous month... Read More »
Health Care M&A Deals, Week Ending November 2, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price ProQR Therapeutics N.V License to QR-1123 $2,500,000 Ophthotech Corporation Inception 4, Inc $11,752,000 Gilead Sciences, Inc. Collaboration on immuno-oncology therapies $50,000,000 Sanofi Collaboration on RIPK1 inhibitor molecules $125,000,000 eHealth... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
